Back to top

Humacyte announces publication of outcomes for patients treated with Symvess

Humacyte (HUMA) announced publication of outcomes for patients with hospital-acquired vascular complications treated with Symvess in the Journal of...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Humacyte, Inc. (HUMA)